Preimplantation genetic testing for aneuploidy: costly or cost effective?

Reflections
Published
Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine
Preimplantation genetic testing for aneuploidy: costly or cost effective?
Like

Volume 110, Issue 5, Page 851

Authors:

Jared C. Robins, M.D, Dana B. McQueen, M.D.

Abstract:

Reflections on "Preimplantation genetic testing for aneuploidy (PGT-A) is cost effective, shortens treatment time, and reduces the risk of failed embryo transfer and clinical miscarriage in select patients when compared to IVF alone" by Neal et al.


Read the full text here.

Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. 

Please sign in or register for FREE

Your Fertility and Sterility Dialog login information is not the same as your ASRM or EES credentials. Users must create a separate account to comment or interact on the Dialog.

Sign In Register

Recommended Content